Skip to main content Accessibility help
×
Home

Surgical Site Infection after Renal Transplantation

  • Anthony D. Harris (a1), Brandon Fleming (a2), Jonathan S. Bromberg (a3), Peter Rock (a4), Grace Nkonge (a5), Michele Emerick (a5), Michelle Harris-Williams (a5) and Kerri A. Thom (a1)...

Abstract

OBJECTIVE

To identify factors associated with the development of surgical site infection (SSI) among adult patients undergoing renal transplantation

DESIGN

A retrospective cohort study

SETTING

An urban tertiary care center in Baltimore, Maryland, with a well-established renal transplantation program that performs ~200–250renal transplant procedures annually

RESULTS

At total of 441 adult patients underwent renal transplantation between January 1, 2010, and December 31, 2011. Of these 441patients, 66 (15%) developed an SSI; of these 66, 31 (47%) were superficial incisional infections and 35 (53%) were deep-incisional or organ-space infections. The average body mass index (BMI) among this patient cohort was 29.7; 84 (42%) were obese (BMI >30). Patients who developed an SSI had a greater mean BMI (31.7 vs 29.4; P=.004) and were more likely to have a history of peripheral vascular disease, rheumatologic disease, and narcotic abuse. History of cerebral vascular disease was protective. Multivariate analysis showed BMI (odds ratio [OR] 1.06; 95% confidence interval [CI], 1.02–1.11) and past history of narcotic use/abuse (OR, 4.86; 95% CI, 1.24–19.12) to be significantly associated with development of SSI after controlling for National Healthcare Surveillance Network (NHSN) score and presence of cerebrovascular, peripheral vascular, and rheumatologic disease.

CONCLUSIONS

We identified higher BMI as a risk factor for the development of SSI following renal transplantation. Notably, neither aggregate comorbidity scores nor NHSN risk index were associated with SSI in this population. Additional risk adjustment measures and research in this area are needed to compare SSIs across transplant centers.

Infect Control Hosp Epidemiol 2015;00(0): 1–7

Copyright

Corresponding author

Address correspondence to Kerri A. Thom, MD, MS, 685 W Baltimore Street, MSTF Suite 334B, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201 (kthom@epi.umaryland.edu).

References

Hide All
1. Klevens, RM, Edwards, JR, Richards, CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160166.
2. Anderson, DJ, Kaye, KS, Classen, D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S51S61.
3. Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725730.
4. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250278; quiz 279–280.
5. National Institutes of Health. 2011 Annual Data Report. National Institute of Diabetes and Digestive and Kidney Institute website. http://kidney.niddk.nih.gov/kudiseases/pubs/kustats. Published June 2012. Accessed December 2014.
6. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309332.
7. Schweizer, ML, Furuno, JP, Harris, AD, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011;11:279.
8. Thom, KA, Johnson, JA, Strauss, SM, Furuno, JP, Perencevich, EN, Harris, AD. Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant Gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:12401246.
9. Deyo, RA, Cherkin, DC, Ciol, MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613619.
10. McGregor, JC, Kim, PW, Perencevich, EN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005;161:483493.
11. Von Korff, M, Wagner, EH, Saunders, K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197203.
12. McGregor, JC, Perencevich, EN, Furuno, JP, et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006;59:12661273.
13. Haley, RW, Culver, DH, Morgan, WM, White, JW, Emori, TG, Hooton, TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206215.
14. Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-System Pharm 2013;70:195283.
15. Lynch, RJ, Ranney, DN, Shijie, C, Lee, DS, Samala, N, Englesbe, MJ. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009;250:10141020.
16. Menezes, FG, Wey, SB, Peres, CA, Medina-Pestana, JO, Camargo, LF. Risk factors for surgical site infection in kidney transplant recipients. Infect Control Hosp Epidemiol 2008;29:771773.
17. Ramos, A, Asensio, A, Munez, E, et al. Incisional surgical site infection in kidney transplantation. Urology 2008;72:119123.
18. Huttunen, R, Syrjanen, J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2013;37:333340.
19. Waisbren, E, Rosen, H, Bader, AM, Lipsitz, SR, Rogers, SO Jr, Eriksson, E. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010;210:381389.
20. Edwards, JR, Peterson, KD, Mu, Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783805.
21. Moehring, RW, Anderson, DJ. “But my patients are different!”: risk adjustment in 2012 and beyond. Infect Control Hosp Epidemiol 2011;32:987989.
22. Sexton, DJ, Chen, LF, Moehring, R, Thacker, PA, Anderson, DJ. Casablanca redux: we are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate. Infect Control Hosp Epidemiol 2012;33:932935.
23. Harris, AD, McGregor, JC. The importance of case-mix adjustment for infection rates and the need for more research. Infect Control Hosp Epidemiol 2008;29:693694.
24. Fraser, TG, Gordon, SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome? Clin Infect Dis 2011;52:14461450.
25. Mu, Y, Edwards, JR, Horan, TC, Berrios-Torres, SI, Fridkin, SK. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol 2011;32:970986.
26. Berrios-Torres, SI, Mu, Y, Edwards, JR, Horan, TC, Fridkin, SK. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 2012;33:463469.

Surgical Site Infection after Renal Transplantation

  • Anthony D. Harris (a1), Brandon Fleming (a2), Jonathan S. Bromberg (a3), Peter Rock (a4), Grace Nkonge (a5), Michele Emerick (a5), Michelle Harris-Williams (a5) and Kerri A. Thom (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed